The results showed that PCMT1 inhibition decreased the levels of P-AKT and P-GSK-3β (Figure 5C), suggesting that PCMT1 may regulate PCa progression by modulating the PI3K/AKT/GSK-3β signaling pathway. The gene discussed is AKT1; the disease is posterior cortical atrophy.